It may not be something you like to talk about, but if you have gastrointestinal (GI) problems, your symptoms may be far more ...

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030.

Live Updates Make sure to refresh this page periodically for updates. Deep Dive into ABBV's Earnings Call 01/01/1970 12:00 am ...

Eight ways to reduce your risk of bowel cancer - Around half of all bowel cancers could be prevented by having a healthier ...

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions ...

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.

The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.

Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

For decades, people in this area have been dealing with unusually high rates of serious health problems, such as multiple sclerosis, ulcerative colitis, Crohn’s disease, and various ...